OBJECTIVE. CT colonography (CTC) has been fully validated as an accurate screening test for colorectal carcinoma and is being disseminated globally. There is an abundance of new literature addressing the prior concerns of the U.S. Preventive Services Task Force and the Centers for Medicare & Medicaid Services. Specific areas related to radiation dose, extracolonic findings, and generalizability of CTC to senior patients are discussed. CONCLUSION. The time has arrived for national reimbursement of CTC in the United States.
|Original language||English (US)|
|Number of pages||7|
|Journal||American Journal of Roentgenology|
|State||Published - Jul 2013|
- CT colonography screening
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging